BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shimoda M, Kubota K. Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol 2007; 13(10): 1500-1504 [PMID: 17461440 DOI: 10.3748/wjg.v13.i10.1500]
URL: https://www.wjgnet.com/1007-9327/full/v13/i10/1500.htm
Number Citing Articles
1
Jong Ryul Eun, Byung Ik Jang, Jun Young Lee, Kyung Ok Kim, Si Hyung Lee, Tae Nyeun Kim, Heon Ju Lee. Clinical Characteristics of Intrahepatic Cholangiocarcinoma and Prognostic Factors in Patients Who Received Non-surgical TreatmentThe Korean Journal of Gastroenterology 2009; 54(4): 227 doi: 10.4166/kjg.2009.54.4.227
2
Murad Aljiffry, Mark J Walsh, Michele Molinari. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009World Journal of Gastroenterology 2009; 15(34): 4240-4262 doi: 10.3748/wjg.15.4240
3
Alphonse E Sirica. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaWorld Journal of Gastroenterology 2008; 14(46): 7033-7058 doi: 10.3748/wjg.14.7033
4
SEN-LIN MA, AI-JUN LI, ZHAO-YANG HU, FU-SHENG SHANG, MENG-CHAO WU. Co-expression of the carbamoyl-phosphate synthase 1 gene and its long non-coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinomaMolecular Medicine Reports 2015; 12(6): 7915 doi: 10.3892/mmr.2015.4435
5
R. Fietkau. Hepatobiliäre und Pankreastumoren2010; : 426 doi: 10.1007/978-3-642-04935-4_43
6
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging2011; : 890 doi: 10.1016/B978-1-4160-5449-8.00086-X
7
QI WANG, HUIHUAN TANG, SHANSHAN YIN, CHAO DONG. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9Oncology Reports 2013; 29(5): 2046 doi: 10.3892/or.2013.2304
8
HAIXIA YANG, JIUPENG ZHOU, XIN WEI, FAN WANG, HUADONG ZHAO, ENXIAO LI. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factorMolecular and Clinical Oncology 2014; 2(6): 1069 doi: 10.3892/mco.2014.377
9
Saini Wang, Anil Kumar Yadav, Jin-Yi Han, Keun Soo Ahn, Byeong-Churl Jang. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1αInternational Journal of Molecular Sciences 2022; 23(11): 6353 doi: 10.3390/ijms23116353
10
Chunxia Wang, Thorsten Maass, Markus Krupp, Florian Thieringer, Susanne Strand, Marcus A. Wörns, Ana-Paula Barreiros, Peter R. Galle, Andreas Teufel. A systems biology perspective on cholangiocellular carcinoma development: Focus on MAPK-signaling and the extracellular environmentJournal of Hepatology 2009; 50(6): 1122 doi: 10.1016/j.jhep.2009.01.024
11
Carsten Kamphues, D. Seehofer, R. M. Eisele, T. Denecke, J. Pratschke, U. P. Neumann, P. Neuhaus. Recurrent intrahepatic cholangiocarcinoma: single‐center experience using repeated hepatectomy and radiofrequency ablationJournal of Hepato-Biliary-Pancreatic Sciences 2010; 17(4): 509 doi: 10.1007/s00534-009-0256-6
12
Manoj K. Singh, Marcelo E. Facciuto. Current Management of CholangiocarcinomaMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 2012; 79(2): 232 doi: 10.1002/msj.21298
13
Seok Ling Ong, Giuseppe Garcea, Kevin Mulcahy, Yvonne Rees, David P. Berry, Ashley R. Dennison. The role of positron emission tomography (PET) in detecting local recurrence cholangiocarcinomaEuropean Journal of Radiology Extra 2008; 68(1): 21 doi: 10.1016/j.ejrex.2008.05.027
14
C. Hillert, X. Rogiers. Hepatobiliäre und Pankreastumoren2010; : 204 doi: 10.1007/978-3-642-04935-4_15
15
Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin, Qi-Jun Qian. Mesothelin-targeting chimeric antigen receptor–modified T cells by piggyBac transposon system suppress the growth of bile duct carcinomaTumor Biology 2017; 39(4): 101042831769594 doi: 10.1177/1010428317695949
16
Laura Elise Horvath, Edgardo Yordan, Deepak Malhotra, Ileana Leyva, Katy Bortel, Denise Schalk, Patricia Mellinger, Marianne Huml, Christy Kesslering, Jeffrey Huml. Multidisciplinary Care in the Oncology Setting: Historical Perspective and Data From Lung and Gynecology Multidisciplinary ClinicsJournal of Oncology Practice 2010; 6(6): e21 doi: 10.1200/JOP.2010.000073
17
Xue Cai, Weigang Ge, Xiao Yi, Rui Sun, Jiang Zhu, Cong Lu, Ping Sun, Tiansheng Zhu, Guan Ruan, Chunhui Yuan, Shuang Liang, Mengge Lyu, Shiang Huang, Yi Zhu, Tiannan Guo. PulseDIA: Data-Independent Acquisition Mass Spectrometry Using Multi-Injection Pulsed Gas-Phase FractionationJournal of Proteome Research 2021; 20(1): 279 doi: 10.1021/acs.jproteome.0c00381
18
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging2011; : 882 doi: 10.1016/B978-1-4160-5449-8.00085-8
19
Gory Ballester-Ortiz, Leonardo Marcal, Chitra Viswanathan, Janio Szklaruk. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 167 doi: 10.1007/978-3-642-40558-7_12
20
Thomas J. Vogl, Nagy N.N. Naguib, Nour‐Eldin A. Nour‐Eldin, Wolf O. Bechstein, Stefan Zeuzem, Jörg Trojan, Tatjana Gruber‐Rouh. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment successInternational Journal of Cancer 2012; 131(3): 733 doi: 10.1002/ijc.26407
21
Kyoji Ito, Yoshihiro Sakamoto, Hiroyuki Isayama, Yosuke Nakai, Takeyuki Watadani, Mariko Tanaka, Tetsuo Ushiku, Nobuhisa Akamatsu, Junichi Kaneko, Junichi Arita, Kiyoshi Hasegawa, Norihiro Kokudo. The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic CholangiocarcinomaJournal of Gastrointestinal Surgery 2018; 22(9): 1528 doi: 10.1007/s11605-018-3793-y
22
Ramesh K. Ramanathan, Chandra P. Belani, Deepti A. Singh, Michael Tanaka, Heinz-Josef Lenz, Yun Yen, Hedy L. Kindler, Syma Iqbal, Jeff Longmate, Philip C. Mack, Georg Lurje, Regina Gandour-Edwards, Janet Dancey, David R. Gandara. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancerCancer Chemotherapy and Pharmacology 2009; 64(4): 777 doi: 10.1007/s00280-009-0927-7
23
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological PerspectivesISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074
24
Junwen Hu, Rongfa Yuan, Changwen Huang, Jianghua Shao, Shubing Zou, Kai Wang. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literatureWorld Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0974-6
25
Mina Komuta, Bart Spee, Sara Vander Borght, Rita De Vos, Chris Verslype, Raymond Aerts, Hirohisa Yano, Tetsuya Suzuki, Masanori Matsuda, Hideki Fujii, Valeer J. Desmet, Masamichi Kojiro, Tania Roskams. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell originHepatology 2008; 47(5): 1544 doi: 10.1002/hep.22238
26
Dakeun Lee, In-Gu Do, Kyusam Choi, Chang Ohk Sung, Kee-Taek Jang, Dongwook Choi, Jin Seok Heo, Seoung Ho Choi, Jongmin Kim, Jin Young Park, Hyung Jin Cha, Jae-Won Joh, Kwan Yong Choi, Dae Shick Kim. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomasModern Pathology 2012; 25(1): 131 doi: 10.1038/modpathol.2011.133
27
Gun Min Kim, Hei-Cheul Jeung, Dokyung Kim, Joo Hoon Kim, Sang Hyun Yoon, Eun Suk Jung, Sang Joon Shin. A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic ChemotherapyCancer Research and Treatment 2010; 42(4): 235 doi: 10.4143/crt.2010.42.4.235
28
Meng-Meng Qu, Yuan-Hui Zhu, Yi-Xiang Li, Zhi-Fan Li, Jin-Kui Li, Yong-Sheng Xu, Manishkumar Shrestha, Jun-Qiang Lei. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinomaMedicine 2021; 100(46): e27349 doi: 10.1097/MD.0000000000027349
29
Sung Ryol Lee, Hyung Ook Kim, Jun Ho Shin. The Strategy of Treatment for Mid to Distal Cholangiocarcinoma after Surgical ResectionThe American Surgeon 2018; 84(6): 820 doi: 10.1177/000313481808400625